Analysts advised investors to hold Groww shares for long term as it represents a strong structural story and can act as a ...

Humacyte (HUMA) just shared new two-year results from its V007 Phase 3 study at Kidney Week 2025. The ATEV device performed better than traditional AV fistulas for hemodialysis access, particularly in ...

Curious if Archer Aviation’s stock is as undervalued as the buzz suggests? You’re not alone, and there’s a lot to unpack beneath the headlines. Despite soaring 87.4% over the past year and an ...